| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161577555P | 2011-12-19 | 2011-12-19 | |
| PCT/US2012/070572WO2013096425A2 (en) | 2011-12-19 | 2012-12-19 | Liquid activation system |
| Publication Number | Publication Date |
|---|---|
| PH12014501307A1true PH12014501307A1 (en) | 2014-09-15 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12014501307APH12014501307A1 (en) | 2011-12-19 | 2014-06-09 | Liquid activation system |
| Country | Link |
|---|---|
| US (1) | US10238590B2 (en) |
| EP (1) | EP2790791B1 (en) |
| JP (1) | JP2015500348A (en) |
| CN (1) | CN104394937B (en) |
| AR (1) | AR089312A1 (en) |
| AU (1) | AU2012359083B2 (en) |
| BR (1) | BR112014014811A2 (en) |
| CA (1) | CA2858257A1 (en) |
| CO (1) | CO6990715A2 (en) |
| HK (1) | HK1201773A1 (en) |
| MX (1) | MX346904B (en) |
| PH (1) | PH12014501307A1 (en) |
| RU (1) | RU2014129870A (en) |
| SG (1) | SG11201402538SA (en) |
| TW (1) | TW201338791A (en) |
| WO (1) | WO2013096425A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014067933A1 (en)* | 2012-10-31 | 2014-05-08 | C-Lecta Gmbh | Bioactive carrier preparation for enhanced safety in care products and food |
| AU2015417677A1 (en)* | 2015-12-17 | 2018-05-31 | Colgate-Palmolive Company | Hydrogen peroxide booster system for enhanced teeth whitening |
| JP7127524B2 (en)* | 2018-12-18 | 2022-08-30 | ライオン株式会社 | oral products |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3678154A (en) | 1968-07-01 | 1972-07-18 | Procter & Gamble | Oral compositions for calculus retardation |
| US3535421A (en) | 1968-07-11 | 1970-10-20 | Procter & Gamble | Oral compositions for calculus retardation |
| US4041149A (en)* | 1976-01-12 | 1977-08-09 | Colgate-Palmolive Company | Composition and method of controlling and preventing mouth odor |
| US4885155A (en) | 1982-06-22 | 1989-12-05 | The Procter & Gamble Company | Anticalculus compositions using pyrophosphate salt |
| US5288480A (en) | 1987-01-30 | 1994-02-22 | Colgate-Palmolive Co. | Antiplaque antibacterial oral composition |
| US4905825A (en) | 1989-07-20 | 1990-03-06 | Brader Allen C | Container having lid activated mixing mechanism |
| US5302373A (en) | 1993-06-10 | 1994-04-12 | Church & Dwight Co., Inc. | Liquid mouthwash containing a particulate bicarbonate suspension |
| CA2300676A1 (en) | 1997-09-02 | 1999-03-11 | Unilever Plc | Oral compositions |
| WO2001072262A2 (en)* | 2000-03-27 | 2001-10-04 | Schott Glas | New cosmetic, personal care, cleaning agent, and nutritional supplement compositions comprising bioactive glass and methods of making and using the same |
| GB2365018A (en)* | 2000-07-24 | 2002-02-13 | Procter & Gamble | Water soluble pouches |
| DE10122380A1 (en) | 2001-05-09 | 2002-11-28 | Schuelke & Mayr Gmbh | Non-alcoholic liquid concentrate for the preservation of cosmetic, household and technical products |
| US7053034B2 (en) | 2002-04-10 | 2006-05-30 | Salvona, Llc | Targeted controlled delivery compositions activated by changes in pH or salt concentration |
| US20040062723A1 (en) | 2002-09-27 | 2004-04-01 | Zaidel Lynette A. | Dual component tooth whitening dentifrice |
| EP1565194A4 (en) | 2002-11-02 | 2007-03-07 | Venture Man Alliance Llc | Aqueous activated components conveyed in a non-aqueous carrier system |
| US20050210615A1 (en) | 2004-03-29 | 2005-09-29 | Ramachandra Shastry | Oral care method |
| US7601002B2 (en) | 2004-03-29 | 2009-10-13 | Colgate-Palmolive Co | Dental whitening method |
| US20060024246A1 (en)* | 2004-07-29 | 2006-02-02 | Prithwiraj Maitra | Oral care compositions with film forming polymers |
| US9271902B2 (en)* | 2005-02-15 | 2016-03-01 | Martin S. Giniger | Whitening system capable of delivering effective whitening action |
| US9289362B2 (en)* | 2005-02-15 | 2016-03-22 | Martin S. Giniger | Foaming compositions and methods |
| WO2007111630A1 (en) | 2005-07-29 | 2007-10-04 | Flexitral, Inc. | Compounds which release an odor on a change in ph |
| HUP0600765A2 (en)* | 2006-10-06 | 2008-10-28 | Istvan Piller | Container for stable carbondioxide foam, process for producing stable carbondioxide foam and method for using of foam |
| MY161557A (en) | 2008-02-08 | 2017-04-28 | Colgate Palmolive Co | Oral care product and methods of use and manufacture thereof |
| US20120283668A1 (en) | 2011-05-04 | 2012-11-08 | Pinchas Shalev | Apparatus and method for using effervescent tablets for cosmetic care |
| Publication number | Publication date |
|---|---|
| EP2790791A2 (en) | 2014-10-22 |
| RU2014129870A (en) | 2016-02-10 |
| CN104394937A (en) | 2015-03-04 |
| CN104394937B (en) | 2017-09-22 |
| EP2790791B1 (en) | 2017-04-19 |
| MX2014007340A (en) | 2014-09-15 |
| CO6990715A2 (en) | 2014-07-10 |
| JP2015500348A (en) | 2015-01-05 |
| WO2013096425A3 (en) | 2014-03-27 |
| HK1201773A1 (en) | 2015-09-11 |
| TW201338791A (en) | 2013-10-01 |
| WO2013096425A2 (en) | 2013-06-27 |
| AU2012359083B2 (en) | 2015-11-26 |
| SG11201402538SA (en) | 2014-10-30 |
| US10238590B2 (en) | 2019-03-26 |
| BR112014014811A2 (en) | 2017-06-13 |
| AU2012359083A1 (en) | 2014-06-19 |
| MX346904B (en) | 2017-04-05 |
| AR089312A1 (en) | 2014-08-13 |
| CA2858257A1 (en) | 2013-06-27 |
| US20150086487A1 (en) | 2015-03-26 |
| Publication | Publication Date | Title |
|---|---|---|
| MX352823B (en) | Protein formulations containing amino acids. | |
| TN2012000543A1 (en) | Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application | |
| NZ717728A (en) | Stable formulations of a hyaluronan-degrading enzyme | |
| PH12015500561A1 (en) | Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same | |
| EA201591474A1 (en) | METHOL MODIFYING ENZYME MODULATORS, COMPOSITIONS AND THEIR APPLICATION | |
| BR112014031424A2 (en) | pluripotent cell treatment | |
| HK1208216A1 (en) | Drug-conjugates, conjugation methods, and uses thereof | |
| PE20191815A1 (en) | STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB | |
| CL2017000498A1 (en) | A highly active phosphorylated human n-acetylgalactosamine-6-sulfatase (galns) formulation (divisional application 219-2013) | |
| CL2008003910A1 (en) | Stable, liquid formulation containing antibody comprising arginine and methionine; A method of inhibiting the deamidation of molecules of an antibody comprising adding arginine to the liquid formulation. | |
| MX2012012023A (en) | Retroreflective articles including optically active areas and optically inactive areas. | |
| BR112016001778A2 (en) | TRANSGENIC YEAST CELL, COMPOSITION, AND, METHODS OF PRODUCTION OF 3-HP AND OF PRODUCTION OF ACRYLIC ACID OR A SALT THEREOF | |
| MX2012003296A (en) | Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin. | |
| AR082943A1 (en) | PREDIGERATED NUTRITIONAL FORMULA | |
| MX2016001006A (en) | Polyconjugates for delivery of rnai triggers to tumor cells in vivo. | |
| MX2014016121A (en) | Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function. | |
| WO2014124307A3 (en) | Targeted theranostics | |
| UA113188C2 (en) | METHOD OF PREPARATION OF HYDROGEL WITH USE OF LIPASE ENZYMES | |
| AU340528S (en) | Insole | |
| PH12014501307A1 (en) | Liquid activation system | |
| TR201009167A2 (en) | Pharmaceutical granules containing cephalosporin. | |
| RS53408B (en) | PHARMACEUTICAL COMPOSITION OF IBUPROFEN FOR INJECTION | |
| IN2014DN04600A (en) | ||
| AR087586A1 (en) | ENZYMATIC SYSTEM | |
| CL2015001302A1 (en) | Method of preparation of 2-alkyl-1,2-bencisothiazolin-3-ones. |